StockWatch
·

Synergy Green Industries Ltd Q2 FY27 Results

SGILQ2 FY27 Results
Filing
Result:Weak· Market: Crashed#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)vs Q1 FY27
Revenue115.7854.1%
Total Income116.3153.6%
Expenditure121.6040.7%
PBT-5.2950.5%
Net Profit-5.0849.7%
OPM9.77%3.47pp
NPM-4.37%8.98pp
EPS-3.27150.2%
View full financials

Manufacturing sector lens (revenue/EBITDA/PAT growth): revenue hit a record +60.8% YoY with OPM still positive at 9.77% and core costs tracking revenue, but the swing from profit to a net loss (driven by capitalised-capex D&A and finance costs, not a turnaround) caps this at weak per the loss/non-turnaround hard rule.

SYNERGY GREEN INDUSTRIES · Q2 FY27 · THE VERDICT

Revenue Surges 60%, But Profits Turn Negative—Margin Guidance Crumbling

Synergy's quarterly revenue smashed guidance, driven by strong OEM wins and export acceleration. Yet a ₹5.1 Cr net loss in Q2 reveals severe margin compression: the company's 16%+ PBDIT guidance is undershooting badly, and management hasn't reset expectations.

06 Nov 2026 · 6 min read
Q2 Revenue

₹115.8 Cr

+60.8% YoY, +54.1% QoQ

Q2 Net profit

-₹5.1 Cr

loss vs profit prior year (PAT -315.3% YoY)

OPM (Q2)

9.8%

vs 16%+ guided, 15.7% prior year

PBDIT margin (H1)

8.9%

vs 15.6% prior year (down 670 bps)

Synergy Green delivered the quarter in two halves: the first half looks like a win, the second half reads like a warning. Revenue jumped 60.8% year-over-year to ₹115.8 Cr—beating its own 33% FY27 guidance at this pace—and the order book expanded materially (Nordex ₹200+ Cr US orders, Vestas confirmed, Siemens Gamesa and Envision in development). The export mix is accelerating toward 30% of revenue (from 25%), and the company is on track to deliver ₹500 Cr annual revenue. All of this is real. But it published a net loss of ₹5.1 Cr in Q2, and the operating margin collapsed to 9.8% from 15.7% the prior year. That gap is the story: revenue strength masking severe execution trouble.

Where the margin went

The company's prior guidance called for 16%+ PBDIT margins for FY27; H1 delivered 8.9%, Q2 specifically 10.2%. Management blames a toxic trio: raw material inflation (furan resin and pig iron up ~50%), elevated logistics costs (20–30% higher), and electricity tariff increases (20% in Maharashtra, retroactively charged two years). Production volume grew 25.8% YoY, but revenue grew only 20.2% QoQ—the gap is unshipped inventory, sitting on the balance sheet as working capital drag while shipping constraints (Maersk delays, war-induced carrier capacity) slow cash realization. The company passed through roughly 8% of the cost increase to customers; the rest is borne in-house. With 12-month contract locks in place, margin recovery hinges on input price stabilization (slated for Q3 price indexation on CRC and pig iron) and inventory clearance (October shipments ramping to 60–70%).

PBDIT Margin, %
06.5313.0719.615.7Prior year (Q2 FY26)10.2Q2 FY27 delivered17.5H2 FY27 guided
Management guided 16%+ for full year; delivered 10.2% in Q2. H2 guidance of 17–18% EBITDA implies ~13% blended FY27 if Q3-Q4 stabilization holds.
Management's claims vs. what holds up

FY27 revenue ₹500 Cr (33% growth) on track

Supported

Q2 +60.8% YoY, H1 +25.8%. Paced ahead of 33% full-year target.

16%+ PBDIT margins expected full year

Overstated

H1 8.9%, Q2 10.2%. H2 guidance 17–18% EBITDA implies ~13% blended FY27.

Inventory buildup will not impact revenue recognition

Supported

Confirmed: production +25.8% YoY, revenue +20.2% QoQ; unshipped sits as balance-sheet cost.

Export revenues to grow 50% this year; reach 30% of total

Supported

Currently 25% of revenue; targeting 30%. Nordex US wins and Vestas confirm pull-through.

80% capacity utilization achievable for FY27

Supported

H1 at 75%, targeting 85% by year-end. Weighted ~80% full year remains on track.

What changed on this call

  • OEM order book expanded materially: Nordex (₹200+ Cr US orders), Vestas confirmed, Siemens Gamesa and Envision in pipeline. Demand stated as 60k+ tons vs 45k capacity—supply constraint, not demand.

  • Export revenue mix accelerating: targeting 30% of revenue (from 25%), 50% export growth expected. US market now primary driver (GE exited, Nordex entered); tariff advantage vs China is defensible.

  • Greenfield project pushed out: land acquisition 15–18 months away, full project 2–3 years. Prioritizing stabilization of 45k-ton capacity first; greenfield deprioritized near-term.

  • Net profitability turned negative: -₹5.1 Cr in Q2 vs profit prior year. Management deflected with EBITDA argument when pressed; targeting 'half-a-percent loss or 0.5% profit' by year-end.

  • Revenue guidance maintained, margin guidance implicitly cut: FY27 ₹500 Cr (33% growth) reaffirmed, but PBDIT margin guidance downgraded from 16%+ to ~13% blended (per H2 17–18% EBITDA guidance).

The bull-bear ledger

  • Revenue growth beats guidance pace: +60.8% Q2 YoY vs 33% FY27 guided. Strong demand and OEM traction driving beat.

  • Major OEM wins provide multi-year visibility: Nordex, Vestas, Siemens Gamesa, Envision wins secured. Non-Chinese supply advantage in US market is structurally defensible.

  • Capacity constrained, not demand constrained: 60k+ tons demand vs 45k capacity. Greenfield (100k-ton target) provides multi-year growth runway.

  • Reported profit turned negative despite 60% revenue growth: -₹5.1 Cr Q2 loss signals severe execution challenge. Margin guidance miss is material (16%+ → ~13% blended).

  • Input cost inflation not yet stabilized: 50% raw material increase, 20–30% logistics elevation. Only 8% passed to customers; rest borne in-house. Recovery contingent on Q3 indexation and cost stabilization.

  • Inventory buildup and working capital drag: unshipped inventory inflates balance sheet; cash realization delayed to Q3-Q4. Shipping constraints (Maersk, war) adding execution risk.

  • Heavy depreciation obscuring true cash profit: capex for machine shop and facilities depreciating on P&L; cash profit may be stronger than reported. But EBITDA guidance also undershooting (10% vs 16%+ prior).

  • Customer concentration risk: Nordex + Vestas account for bulk of new wins. OEM capex cycle slowdown could crater order book near-term.

  • Greenfield execution and funding deferred: 2–3 year timeline, no formal capex budget disclosed. Land acquisition and capital raise remain execution wildcards.

Risks, ranked by how much they should concern a holder

Near-term and structural risks sorted by severity

Input cost inflation and margin pressure persist beyond Q3

High

If furan resin, pig iron, and logistics costs don't stabilize or if customers resist further price increases, FY27 margins will remain stuck at 10–12% EBITDA (vs 16%+ guided). This would extend net losses and force another guidance cut.

Net profitability not recovered by year-end

High

Management deflected on when PAT turns positive, pivoting to EBITDA instead. If cash profit doesn't materialize even in H2, it signals the margin miss is structural, not cyclical. Analyst skepticism on this point is warranted.

Inventory and working capital drag extends into Q4

High

If Maersk delays persist or if ODC constraints continue, the 5.6 percentage-point gap between production and revenue growth will deepen. Unshipped inventory inflates balance sheet and delays cash realization.

OEM capex cycle slowdown (renewable energy macros)

Medium

Nordex and Vestas account for most new order wins. If renewable energy capex cycles slow globally or if OEM demand shifts to competitors (China, Europe), Synergy's order book could deflate rapidly.

Greenfield project delayed or underfunded

Medium

Greenfield land acquisition is 15–18 months away; full capex rollout is 2–3 years. If capital markets tighten or market cap compresses, equity dilution risk rises. Competitors may expand faster, capturing market share.

Rupee depreciation elevates capex and import costs

Medium

Rupee is down 25% vs RMB in 18 months. While this aids export pricing, it increases capex costs for greenfield and import costs for raw materials. Currency acceleration would delay margin recovery.

How the street is positioned

The stock is trading at ₹555.9, down 20.35% from its all-time high of ₹697.95 and below its 20-, 50-, and 200-day moving averages. The drawdown reflects market skepticism on margin recovery and profitability inflection. FII ownership has collapsed from 0.42% in Q2 FY26 to 0.23% in Q1 FY27—institutional investors are trimming exposure as the margin guidance crumbles. DII has crept up marginally (1.73% in Q1 FY27 vs 1.51% in Q4 FY26), but the overall picture is institutional outflow. Promoter ownership remains rock-solid at 69.5%, which signals long-term conviction but also that the market doesn't trust the near-term recovery narrative. The stock has rallied 32% off its 52-week low of ₹420 but is still down a fifth from its highs—a classic risk-off trade where near-term execution doubt outweighs long-term upside. Post-result momentum is likely muted or negative until Q3 guidance and margin recovery become visible.

What to watch next
  • 1 · Q3 guidance and PBDIT margin recovery

    If H1 PBDIT was 8.9% and management guided H2 at 17–18% EBITDA, Q3 will be the first test. Look for PBDIT to rebound toward 12–14% at minimum. If it stays stuck at 10–11%, the margin miss is structural, and the bear case accelerates.

  • 2 · Net profit inflection and cash conversion

    Management targeted 'half-a-percent loss or 0.5% profit' by year-end. Q3 should show path to positive PAT; if not, the market will interpret it as lack of cash profit visibility and re-rate the stock lower.

  • 3 · Inventory clearance and working capital normalization

    October shipments ramped to 60–70%; Q3 should show material inventory rundown. If unshipped inventory persists beyond Q3, the working capital drag will extend into Q4 and delay cash realization.

  • 4 · Greenfield land acquisition and capex detail

    The 15–18 month timeline for greenfield land acquisition is vague. Any concrete announcement on land, capex budget, or equity raise would clarify execution risk and de-risk the long-term thesis.

Synergy Green Industries is a steady long-term execution story turning into a near-term question mark. Revenue growth is real and impressive—60.8% YoY well ahead of the 33% guidance—and the OEM order book expansion (Nordex, Vestas, Siemens Gamesa) provides multi-year visibility. But the company's inability to defend profitability in a quarter of 60% revenue growth is a red flag. Margin guidance has been implicitly slashed from 16%+ to ~13% blended, and management's deflection on net losses to EBITDA suggests limited confidence in cash profit recovery. The stock's 20% drawdown from all-time high is not entirely unwarranted; near-term execution risk is material. The single number to track from here is Q3 PBDIT margin: if it rebounds toward 12–14%, the margin miss is cyclical and the bull case remains intact. If it stalls at 10–11%, the bear case accelerates and the stock has further downside.

Informational and educational content only. Not investment advice.